Morphine Sulfate Tablet
Brand names: Morphine Sulfate
Category: Analgesia/Addiction
FDA status: To Be Discontinued · Last FDA update: Dec 22, 2025 · First posted: Dec 22, 2025 · 1 manufacturers, 2 listed presentations
As of Dec 22, 2025, the FDA lists Morphine Sulfate Tablet as being discontinued. Of 2 manufacturer presentations, 2 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Morphine Sulfate, Tablet, 15 mg (NDC 0832-0273-11) NDC 0832-0273-11 |
Upsher-Smith Laboratories, LLC | Not specified | Discontinuation of the manufacture of the drug |
| Morphine Sulfate, Tablet, 30 mg (NDC 0832-0274-11) NDC 0832-0274-11 |
Upsher-Smith Laboratories, LLC | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Analgesia/Addiction medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Morphine Sulfate Tablet (FDA data as of Dec 22, 2025). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Morphine Sulfate Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/morphine-sulfate-tablet.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).